Arecor Therapeutics' (LON:AREC) CEO Sarah Howell joins Proactive London on the first day of their London listing. The firm has raised £20 million in the oversubscribed IPO, receiving strong support from investors.
Howell explains what the money will be used for, progressing their lead diabetes products as well as developing and expanding their pipeline of specialty hospital ready-to-use and ready-to-administer products.